Injection site reactions due to the use of biologics in patients with psoriasis: A retrospective study
暂无分享,去创建一个
M. Yoon | Y. Jang | Hee-Jung Lee | D. H. Kim | Jung U Shin
[1] L. Puig,et al. Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials , 2022, Advances in Therapy.
[2] F. Prignano,et al. Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review , 2020, Rheumatology and Therapy.
[3] V. Shi,et al. Classification and mitigation of negative injection experiences with biologic medications , 2020, Dermatologic therapy.
[4] Y. Ramot,et al. Injection site reactions with the use of biological agents , 2019, Dermatologic therapy.
[5] Byung Soo Kim,et al. The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE) , 2017, Annals of dermatology.